Shanghai, China

Zhangcheng Chen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Shanghaitech University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhangcheng Chen. Retrieved from https://idiyas.com/inventor/zhangcheng-chen-ec53bgvt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Zhangcheng Chen in Aza-Ergoline Derivatives

Introduction

Zhangcheng Chen is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly through his work on aza-ergoline derivatives. His innovative approach has led to advancements in the understanding and application of these compounds.

Latest Patents

Zhangcheng Chen holds a patent for an aza-ergoline derivative and its preparation method, as well as its application. The patent describes a derivative that exhibits good affinity, agonistic activity, or selectivity to the dopamine D2 receptor. This innovation is crucial for developing new therapeutic agents targeting neurological disorders.

Career Highlights

Throughout his career, Zhangcheng Chen has been associated with prestigious institutions such as ShanghaiTech University and the Chinese Academy of Sciences. His work in these organizations has allowed him to collaborate with leading researchers and contribute to significant scientific advancements.

Collaborations

Zhangcheng Chen has worked alongside esteemed colleagues, including Jianjun Cheng and Sheng Wang. Their collaborative efforts have further enhanced the research and development of innovative compounds in the field.

Conclusion

Zhangcheng Chen's contributions to the field of aza-ergoline derivatives highlight his role as a prominent inventor. His work not only advances scientific knowledge but also paves the way for potential therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…